Yulia Ron

2.0k citations

47 papers · 1.1k indexed · h-index 14

Impact in

Genetics top 2%
- Inflammatory Bowel Disease
Gastroenterology top 5%

Papers in ⓘ

Genetics 32
- Inflammatory Bowel Disease 32
Epidemiology 21
- Microscopic Colitis 18

Co-authors: Iris Dotan (22 shared papers)Henit Yanai (21 shared papers)Shomron Ben‐Horin (13 shared papers)Yehuda Chowers (8 shared papers)Lev Lichtenstein (4 shared papers)Rami Eliakim (9 shared papers)Uri Kopylov (14 shared papers)Batia Weiss (4 shared papers)
Journals: Journal of Crohn s and Colitis (11 papers)Gastroenterology (8 papers)Alimentary Pharmacology & Therapeutics (3 papers)Journal of Clinical Medicine (2 papers)Digestive Diseases (2 papers)
Partner nations: Israel Italy United Kingdom

In The Last Decade

Yulia Ron

43 papers receiving 1.1k citations

Peers

Countries citing papers authored by Yulia Ron

Since Specialization

Citations

This map shows the geographic impact of Yulia Ron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulia Ron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulia Ron more than expected).

Fields of papers citing papers by Yulia Ron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulia Ron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulia Ron. The network helps show where Yulia Ron may publish in the future.

Co-authors

The 25 scholars most cited alongside Yulia Ron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yulia Ron Line = papers co-authored together Yulia Ron links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab Clinical Gastroenterology and Hepatology ·Henit Yanai, Lev Lichtenstein, Amit Assa, Yoav Mazor, Batia Weiss, Arie Levine, Yulia Ron, Uri Kopylov, Yoram Bujanover, Yoram Rosenbach, Bella Ungar, Rami Eliakim, Yehuda Chowers, Raanan Shamir, Gerald Fraser, Iris Dotan, Shomron Ben‐Horin	2014	236
2	Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease Inflammatory Bowel Diseases ·Iris Dotan, Yulia Ron, Henit Yanai, Stuart A. Becker, Sigal Fishman, Lior Yahav, Merav Ben Yehoyada, Diane R. Mould	2014	224
3	Infliximab-Related Infusion Reactions: Systematic Review Journal of Crohn s and Colitis ·Lev Lichtenstein, Yulia Ron, Shmuel Kivity, Shomron Ben‐Horin, Eran Israeli, Gerald Fraser, Iris Dotan, Yehuda Chowers, Ronit Confino‐Cohen, Batia Weiss	2015	159
4	Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience Inflammatory Bowel Diseases ·Uri Kopylov, Yulia Ron, Irit Avni‐Biron, Benjamin Koslowsky, Matti Waterman, Saleh Daher, Bella Ungar, Henit Yanai, Nitsan Maharshak, Ofer Ben‐Bassat, Lev Lichtenstein, Ariella Bar‐Gil Shitrit, Eran Israeli, Doron Schwartz, Eran Zittan, Rami Eliakim, Yehuda Chowers, Shomron Ben‐Horin, Iris Dotan	2017	82
5	Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis Alimentary Pharmacology & Therapeutics ·Bella Ungar, Yoav Mazor, Roni Weisshof, Henit Yanai, Yulia Ron, Idan Goren, Amir Waizbard, Miri Yavzori, Ella Fudim, Orit Picard, Ronen Loebstein, Uri Kopylov, Iris Dotan, Yehuda Chowers, Rami Eliakim, Shomron Ben‐Horin	2016	62
6	The decline of anti‐drug antibody titres after discontinuation of anti‐TNFs: implications for predicting re‐induction outcome in IBD Alimentary Pharmacology & Therapeutics ·Shomron Ben‐Horin, Yoav Mazor, Henit Yanai, Yulia Ron, Uri Kopylov, Miri Yavzori, Orit Picard, Ella Fudim, ‪Yasmin Maor‬‏, Adi Lahat, D. Coscas, Rami Eliakim, Iris Dotan, Yehuda Chowers	2012	47
7	Evaluation of a new pan-enteric video capsule endoscopy system in patients with suspected or established inflammatory bowel disease – feasibility study SHILAP Revista de lepidopterología ·Rami Eliakim, Cristiano Spada, Alon Lapidus, Inbal Eyal, Silvia Pecere, Ignacio Fernández-Urién, Adi Lahat, Guido Costamagna, Avraham Schwartz, Yulia Ron, Henit Yanai, Samuel N. Adler	2018	43
8	Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills European Journal of Gastroenterology & Hepatology ·Anat Yerushalmy‐Feler, Yulia Ron, Efrat Barnea, Ayala Nachum, Shay Matalon, Margalit Dali‐Levy, Iris Dotan, Shlomi Cohen	2017	33
9	Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study United European Gastroenterology Journal ·Nathaniel A. Cohen, Nikolas Plevris, Uri Kopylov, A Grinman, Bella Ungar, Henit Yanai, Haim Leibovitzh, Naomi Fliss‐Isakov, Ayal Hirsch, Einat Ritter, Yulia Ron, Ariella Bar‐Gil Shitrit, Eran Goldin, Iris Dotan, Shomron Ben‐Horin, Charlie W. Lees, Nitsan Maharshak	2020	32
10	Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome Neurogastroenterology & Motility ·Keren Hod, Ram Dickman, Ami D. Sperber, Samuel Melamed, Roy Dekel, Yulia Ron, Zamir Halpern, Shlomo Berliner, Nitsan Maharshak	2011	28
11	Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study Alimentary Pharmacology & Therapeutics ·Irit Avni‐Biron, Tali Mishael, Eran Zittan, Moran Livne‐Margolin, Adar Zinger, Roie Tzadok, R Goldenberg, Uri Kopylov, Yulia Ron, Eran Hadar, Sarit Helman, Sorina Grisaru Granovsky, Jacob E. Ollech, Ayelet Arazi, Rivka Farkash, Maor H. Pauker, Henit Yanai, Iris Dotan, Ariella Bar‐Gil Shitrit	2022	24
12	The Effect of Acarbose on the Colonic Transit Time of Elderly Long-term Care Patients With Type 2 Diabetes Mellitus The Journals of Gerontology Series A ·Yulia Ron, Julio Wainstein, Arthur Leibovitz, N. Monastirsky, Beni Habot, Yona Avni, R Segal	2002	22
13	Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience Digestive and Liver Disease ·Uri Kopylov, Irit Avni‐Biron, Yulia Ron, Benjamin Koslowsky, Matti Waterman, Saleh Daher, Bella Ungar, Doron Schwartz, Eran Zittan, Michal Openhaim, Henit Yanai, Nitsan Maharshak, Ariella Bar Gil Shitrit, Timna Naftali, Rami Eliakim, Yehuda Chowers, Shomron Ben‐Horin, Iris Dotan	2018	21
14	Risk Factors for Malnutrition among IBD Patients Nutrients ·Larisa Einav, Ayal Hirsch, Yulia Ron, Nathaniel A. Cohen, Sigalit Lahav, Jasmine Kornblum, Ronit Anbar, Nitsan Maharshak, Naomi Fliss‐Isakov	2021	19
15	Immune function in newborns with in-utero exposure to anti-TNFα therapy Frontiers in Pediatrics ·Batia Weiss, Shomron Ben‐Horin, Atar Lev, Efrat Broide, Miri Yavzori, Adi Lahat, Uri Kopylov, Orit Picard, Rami Eliakim, Yulia Ron, Irit Avni‐Biron, Anat Yerushalmy‐Feler, Amit Assa, Raz Somech, Ariella Bar‐Gil Shitrit	2022	13
16	Development and validation of processed foods questionnaire (PFQ) in adult inflammatory bowel diseases patients European Journal of Clinical Nutrition ·Chen Sarbagili‐Shabat, Shira Zelber‐Sagi, Naomi Fliss‐Isakov, Yulia Ron, Ayal Hirsch, Nitsan Maharshak	2020	11
17	Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center Journal of Clinical Medicine ·Naomi Fliss‐Isakov, Nathaniel A. Cohen, Ahuva Bromberg, Gal Elbert, Ronit Anbar, Yulia Ron, Ayal Hirsch, Tamar Thurm, Nitsan Maharshak	2023	10
18	Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study Gut ·Nathan Gluck, Elizabeth Half, Vered Bieber, Doron Schwartz, Yulia Ron, Ian M. Gralnek, Amir Klein, Jesse Lachter, Moshe Shoni Levy, Menachem Moshkowitz, Nadir Arber	2018	9
19	Ultra-Processed Foods Consumption Is Positively Associated with the Clinical Activity of Inflammatory Bowel Diseases: A Cross-Sectional Single-Center Study Inflammatory Intestinal Diseases ·Chen Sarbagili‐Shabat, Shira Zelber‐Sagi, Naomi Fliss‐Isakov, Ayal Hirsch, Yulia Ron, Laura Sol Grinshpan, Ronit Anbar, Ahuva Bromberg, Tamar Thurm, Nitsan Maharshak	2024	7
20	Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire United European Gastroenterology Journal ·Gaiana Ostromohov, Morin Fibelman, Ayal Hirsch, Yulia Ron, Nathaniel A. Cohen, Revital Kariv, Liat Deutsch, Jasmine Kornblum, Ronit Anbar, Nitsan Maharshak, Naomi Fliss‐Isakov	2021	7

About Yulia Ron

Yulia Ron is a scholar working on Genetics, Epidemiology, Surgery, Gastroenterology and Immunology, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (32 papers), Microscopic Colitis (18 papers), Eosinophilic Esophagitis (11 papers), Celiac Disease Research and Management (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Gastrointestinal Bleeding Diagnosis and Treatment (4 papers), Biosimilars and Bioanalytical Methods (4 papers) and Gastrointestinal motility and disorders (3 papers). The work is most often cited by research in Genetics (793 citations), Gastroenterology (136 citations), Immunology (411 citations), Epidemiology (600 citations) and Surgery (273 citations). Yulia Ron has collaborated with scholars based in Israel, Italy and United Kingdom. Frequent co-authors include Iris Dotan, Henit Yanai, Shomron Ben‐Horin, Yehuda Chowers, Lev Lichtenstein, Rami Eliakim, Uri Kopylov, Batia Weiss, Gerald Fraser and Sigal Fishman. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Alimentary Pharmacology & Therapeutics, Journal of Clinical Medicine and Digestive Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact